title: Heat denaturation, a simple method to improve the immunotherapeutic potential of allergens.
abstract: Allergen-specific immunotherapy (SIT) leads to a long-term amelioration of IgE- and Th2-mediated allergic diseases. However, SIT efficiency is low, with years of treatment along with frequent allergic side effects. The goal of this study was to reduce the side effects by destroying IgE-binding epitopes, i.e. by heat-denaturation, while preserving the therapeutic effect. Mice were immunised with bee venom, birch pollen, grass pollen or cat hair allergens, or with ovalbumin. Heat-denatured allergens bound less IgE but enhanced Th1-dependent IgG2a production as measured by ELISA. The strong IgG2a antibody responses also prevented allergic anaphylaxis in mice, as measured by body temperature drop after a challenge with a high allergen dose. We found that optimal heat-denaturation of allergens left a small proportion in the native conformation to sufficiently stimulate B cells, while non-B cell-mediated effects were probably amplified. The enhanced immunogenicity of heat-denatured allergens is likely explained by enhanced antigen presentation to T cells due to the particulate nature of heat-denatured proteins. This enables Th1 skewing of the immune response with strong production of IgG2a in mice. Therefore, heat-denaturation represents probably the simplest way to enhance the efficiency of SIT while reducing its side effects.
authors.affiliation: Unit for Experimental Immunotherapy, University Hospital of Zurich, Zurich, Switzerland. pal.johansen@usz.ch
authors.forename: Pål
authors.initials: P
authors.lastname: Johansen
authors.forename: Gabriela
authors.initials: G
authors.lastname: Senti
authors.forename: Julia Maria
authors.initials: JM
authors.lastname: Martínez Gómez
authors.forename: Brunello
authors.initials: B
authors.lastname: Wüthrich
authors.forename: Adrian
authors.initials: A
authors.lastname: Bot
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Kündig
mesh_terms: D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D001666:Binding Sites, Antibody; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006358:Hot Temperature; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007132:Immunoglobulin Isotypes / Q000096:biosynthesis; D051379:Mice; D008808:Mice, Inbred CBA; D011489:Protein Denaturation
chemical_list: D000485:Allergens; D007074:Immunoglobulin G; D007132:Immunoglobulin Isotypes